Related changes
Jump to navigation
Jump to search
Enter a page name to see changes on pages linked to or from that page. (To see members of a category, enter Category:Name of category). Changes to pages on your Watchlist are in bold.
List of abbreviations:
- N
- This edit created a new page (also see list of new pages)
- m
- This is a minor edit
- b
- This edit was performed by a bot
- (±123)
- The page size changed by this number of bytes
24 April 2024
|
N 21:26 | Tranexamic 7 changes history +23,022 [Alara E. Dagsali (7×)] | |||
|
21:26 (cur | prev) +14 Alara E. Dagsali talk contribs Tag: Manual revert | ||||
|
21:26 (cur | prev) −11 Alara E. Dagsali talk contribs | ||||
|
21:25 (cur | prev) −2 Alara E. Dagsali talk contribs Tag: Manual revert | ||||
|
21:23 (cur | prev) −1 Alara E. Dagsali talk contribs | ||||
|
21:23 (cur | prev) +3 Alara E. Dagsali talk contribs Tag: Visual edit: Switched | ||||
|
21:22 (cur | prev) −1 Alara E. Dagsali talk contribs | ||||
N |
|
21:14 (cur | prev) +23,020 Alara E. Dagsali talk contribs (Created page with "{{DrugProjectFormSinglePage |authorTag=Alara E.Dagsali |genericName=Tranexamic |aOrAn=a |drugClass=hemophilia drug |indicationType=prevention |indication=Tranexamic acid injection is indicated in patients with hemophilia for short-term use (2 to 8 days) to reduce or prevent hemorrhage and reduce the need for replacement therapy during and following tooth extraction. |adverseReactions=Thromboembolic Risk Seizures Hypersensitivity Reactions Visual Disturbances Dizzines...") |